LanzaTech's Pathway to Decarbonization Pitch

Financial Benchmarking 2025E EBITDA / Capital Expenditures | 2025E EBITDA Margins 2025E EBITDA Margin 40% *gevo (0x, 51%) 35% 30% ORIGIN 25% GINKGO BIOWORKS™ THE ORGANISM COMPANY 20% ITM 15% POWER PLUG POWER 10% 5% NESTE 0% 0x 1 x 2 x 3 x LanzaTech 4 x LanzaTech novozymes AKER C CAPTUREBON stem -chargepoin+ amyris Synthetic Biology Sustainable Materials / Fuels Decarbonization Enablers 5 x 6 x 7 x 8 x 9 x 10 x 2025E EBITDA / Capital Expenditures Source: Lanza Tech management, Public disclosures, Capital IQ, Bloomberg and IBES Estimates; market data as of 02-Mar-2022 Note: Lanza Tech Adjusted EBITDA adds back stock-based compensation and includes Lanza Tech's share of LanzaJet's Net Income. EBITDA measures may not be directly comparable between companies presented. 45

View entire presentation